The designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...